Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 30;18(6):2124785.
doi: 10.1080/21645515.2022.2124785. Epub 2022 Oct 12.

CIMT 2022: Report on the 19th Annual Meeting of the Association for Cancer Immunotherapy

Peer Andre Berger  1 , Janina Freitag  2 , Sophie-Christin Linkenbach  2 , Lukas Merz  2 , Maik Schork  2 , Sophia Thevissen  2 , Ikra Yildiz  2 , Jan D Beck  1
Affiliations

CIMT 2022: Report on the 19th Annual Meeting of the Association for Cancer Immunotherapy

Peer Andre Berger et al. Hum Vaccin Immunother. .

Abstract

The 19th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Europe's cancer immunotherapy meeting, was the first in-person event organized by CIMT since the beginning of the COVID-19 pandemic. As a hybrid event from May 10-12, the meeting attracted 920 academic and clinical professionals from over 40 countries, who met to discuss the latest advances in cancer immunology and immunotherapy research. This report summarizes the highlights of CIMT2022.

Keywords: CIMT; cancer immunotherapy; cellular therapy; checkpoint blockade; combination therapy; personalized therapy; tumor microenvironment; tumor vaccination.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Similar articles

See all similar articles

References

    1. Gros A, Robbins PF, Yao X, Li YF, Turcotte S, Tran E, Wunderlich JR, Mixon A, Farid S, Dudley ME, et al. PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors. J Clin Invest [Internet]. 2014;124(5):1–11. doi:10.1172/JCI73639. - DOI - PMC - PubMed
    1. Gros A, Parkhurst MR, Tran E, Pasetto A, Robbins PF, Ilyas S, Prickett TD, Gartner JJ, Crystal JS, Roberts IM, et al. Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients. Nat Med [Internet]. 2016;22(4):433–38. doi:10.1038/nm.4051. - DOI - PMC - PubMed
    1. Gorris MAJ, van der Woude LL, Kroeze LI, Bol K, Verrijp K, Amir AL, Meek J, Textor J, Figdor CG, de Vries IJM.. Paired primary and metastatic lesions of patients with ipilimumab-treated melanoma: high variation in lymphocyte infiltration and HLA-ABC expression whereas tumor mutational load is similar and correlates with clinical outcome. J Immunother Cancer [Internet]. 2022;10. http://www.ncbi.nlm.nih.gov/pubmed/35550553. - PMC - PubMed
    1. DuPage M, Dooley AL, Jacks T. Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nat Protoc [Internet]. 2009;4(7):1064–72. doi:10.1038/nprot.2009.95. - DOI - PMC - PubMed
    1. DuPage M, Cheung AF, Mazumdar C, Winslow MM, Bronson R, Schmidt LM, Crowley D, Chen J, Jacks T. Endogenous T cell responses to antigens expressed in lung adenocarcinomas delay malignant tumor progression. Cancer Cell [Internet]. 2011;19(1):72–85. doi:10.1016/j.ccr.2010.11.011. - DOI - PMC - PubMed